Safety and efficacy of TNFα blockade in relapsing vasculitis

被引：68

作者：

Booth, AD

Jefferson, HJ

Ayliffe, W

Andrews, PA

Jayne, DR

机构：

[1] Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England

[2] St Helier Hosp, SW Thames Renal & Transplantat Unit, Carshalton SM1 AA, Surrey, England

[3] Mayday Univ Teaching Hosp, Croydon CR7 7YE, England

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2002年 / 61卷 / 06期

关键词：

D O I：

10.1136/ard.61.6.559

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：559 / 559

页数：1

共 7 条

[1] Isolated digital vasculitis in a patient with rheumatoid arthritis:: good response to tumour necrosis factor α blocking treatment [J].

den Broeder, AA ;

van den Hoogen, FHJ ;

van de Putte, LBA .

ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (05) :538-539

[2]

LUQMANI RA, 1994, Q J MED, V87, P671

[3] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[4] Effect of infliximab on sight-threatening panuveitis in Behcet's disease [J].

Sfikakis, PP ;

Theodossiadis, PG ;

Katsiari, CG ;

Kaklamanis, P ;

Markomichelakis, NN .

LANCET, 2001, 358 (9278) :295-296

[5]

Stone JH, 2001, ARTHRITIS RHEUM, V44, P1149, DOI 10.1002/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO

[6]

2-F

[7] A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease [J].

Targan, SR ;

Hanauer, SB ;

vanDeventer, SJH ;

Mayer, L ;

Present, DH ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

Rutgeerts, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) :1029-1035

← 1 →